FB
WST icon

Fulton Bank’s West Pharmaceutical WST Stock Holding History

Fulton Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866K Buy
2,411
+226
+10% +$69.1K 0.03% 356
2026
Q1 		$548K Buy
2,185
+415
+23% +$103K 0.02% 426
2025
Q4 		$487K Buy
1,770
+316
+22% +$86.4K 0.02% 455
2025
Q3 		$381K Buy
1,454
+57
+4% +$13.9K 0.01% 497
2025
Q2 		$306K Buy
1,397
+176
+14% +$37.6K 0.01% 547
2025
Q1 		$273K Buy
1,221
+72
+6% +$19.8K 0.01% 551
2024
Q4 		$376K Buy
1,149
+103
+10% +$32.4K 0.01% 490
2024
Q3 		$314K Sell
1,046
-136
-12% -$41.6K 0.01% 535
2024
Q2 		$389K Sell
1,182
-13
-1% -$4.59K 0.02% 449
2024
Q1 		$473K Buy
1,195
+139
+13% +$51.4K 0.02% 394
2023
Q4 		$372K Buy
1,056
+243
+30% +$86K 0.02% 431
2023
Q3 		$305K Buy
+813
New +$314K 0.02% 448

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fulton Bank's WST Position: Q2 2026 in Review

Fulton Bank increased its West Pharmaceutical (WST) stake by 10% in Q2 2026, buying an estimated $69.1K and bringing the position to 2,411 shares worth $866K. The position accounts for 0.03% of the portfolio, ranked #356.

Fulton Bank first reported a position in WST in Q3 2023 and has held it in 12 quarters since. 121 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Fulton Bank held 2,411 shares of West Pharmaceutical worth $866K as of Q2 2026.
  • Fulton Bank bought 226 West Pharmaceutical shares in Q2 2026, an estimated $69.1K.
  • West Pharmaceutical made up 0.03% of Fulton Bank's portfolio in Q2 2026, its #356 holding.
  • Fulton Bank first reported a position in West Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
  • 121 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.